JESSICA FERNANDEZ: Open Payments
NPI 1104233857 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 26 payments from 12 companies in 2025. Trend: 2023 $597 · 2024 $620 · 2025 $480
Food & beverage: $454Education: $26
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $85 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Daiichi Sankyo Inc. | 4 | $73 |
| Novartis Pharmaceuticals Corporation | 4 | $62 |
| Janssen Biotech, Inc. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| PFIZER INC. | 1 | $19 |
| Genmab U.S., Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
Products named: KEYTRUDA, OJJAARA, ENHERTU, Vanflyta, TALVEY, PLUVICTO, BLENREP, ELREXFIO.
Industry payments across NJ — which companies pay providers there.
